04 Aug 2021 --- China-based yeast and yeast derivatives giant Angel Yeast has surpassed its revenue targets for H1, the period from January 1 to June 30, 2021. Notably, the biotech company reports that revenue increased 20.6 percent year-on-year to RMB 5.234 billion (US$810 million). “Angel Yeast’s performance in H1 remained strong despite the lingering effects of the COVID-19 pandemic and the challenge of increasing costs,” says Xiao Minghua, general manager of Angel Yeast.
